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2000.—Preconditioning the heart by brief coronary (CAO) or
mesenteric artery occlusion (MAO) can protect against dam-
age during subsequent prolonged CAO and reperfusion. The
role of bradykinin (BK) in remote cardiac preconditioning by
MAO is investigated by antagonizing the BK B2 receptor
[Hoechst 140 (HOE-140)] or simulating local BK release by
mesenteric intra-arterial infusion. Anesthetized male Wistar
rats (n 5 6–8) were treated with HOE-140 or saline before
starting the preconditioning protocol, CAO, MAO, or non-pre-
conditioned control. Infarct size related to risk area [ratio of
infarct area to area at risk (IA/AR)] was determined after 3 h
of reperfusion following a 60-min CAO. IA/AR was 62 6 5% in
controls and not affected by HOE-140 (58 6 6%). CAO as well
as MAO significantly protected the heart (IA/AR, 37 6 3 and
35 6 5%), which was prevented by HOE-140 (IA/AR, 71 6 6
and 65 6 7%, respectively). Brief intramesenteric BK infu-
sion mimicked MAO (IA/AR, 26 6 3%). Pretreatment with
hexamethonium could abolish this protection (IA/AR, 67 6
4%). These data indicate an important role for BK in remote
preconditioning by MAO. Results support the hypothesis that
remote preconditioning acts through sensory nerve stimula-
tion in the ischemic organ.
sensory nerves; mesenteric vascular bed
ISCHEMIC PRECONDITIONING has been described for the
myocardium (13) as well as for many other organs,
including brain (8), kidney (23), liver (10), and skeletal
muscle (12), indicating a rather general phenomenon.
However, within the heart, brief local ischemia not only
preconditioned that same area but also adjacent myocar-
dium was protected (15). Moreover, we showed that
even brief ischemia in organs other than the heart was
able to protect the heart (3) (also termed as remote
preconditioning). This has been confirmed by others
(14, 20). The mechanism within the heart showed
similarities with the classical preconditioning (14, 20).
Outside the heart we showed that for the phenomenon
of remote cardiac preconditioning reperfusion of the
stimulated organ is required before coronary artery
occlusion (CAO) and that protection can be abolished by
ganglion blockade with hexamethonium, thus indicat-
ing a neurogenic pathway that is activated during
reperfusion (3). We hypothesized that reperfusion of
the ischemic organ locally stimulates sensory nerves,
which project to efferent nerves on the myocardium.
One of the endogenous substances that is released
during ischemia-reperfusion and capable of activating
sensory nerves is bradykinin (BK). We herein investi-
gate the role of BK in remote cardiac preconditioning by
mesenteric artery occlusion (MAO). To inhibit the ef-
fects of endogenous BK, the BK B2 receptor, responsible
for afferent nerve stimulation, is blocked by its antago-
nist Hoechst 140 (HOE-140). To mimic the effects of
local BK release, the effects of intramesenterically
infused BK (7) to locally stimulate afferent nerves in
the absence or presence of ganglion blockade were
investigated.
MATERIALS AND METHODS
At all stages the experiments conform with the Guide for
the Care and Use of Laboratory Animals. Male Wistar rats
(Harlan; Zeist, The Netherlands) weighing 280–380 g at time
of the experiment were used. Animals were housed in groups
of two or three, placed on a 12:12-h light-dark cycle, and given
food and water ad libitum.
Surgical and experimental preparation. Rats were anesthe-
tized with pentobarbital sodium (60 mg/kg ip) and intubated
(PE-240) for positive pressure ventilation (Harvard Rodent
Ventilator; Hilliston, MA) with room air (60–70 strokes/min,
tidal volume 3 ml). The abdominal aorta was cannulated via
the femoral artery to register mean arterial blood pressure
(MAP) and heart rate (HR). A catheter was placed in the
femoral vein for infusion of pentobarbital sodium to maintain
anesthesia (0.15 mg·kg21 ·min21) and injection of HOE-140
or saline. An additional catheter was positioned in the right
atrium via the right jugular vein for infusion of Haemaccell
(Behringwerke; Marburg, Germany) to compensate for car-
diac effects of (surgery associated) fluid loss by maintaining
right ventricular filling pressure at 5 mmHg. Then, the fourth
intercostal space was opened, and a 6-0 silk suture was looped
under the left descending coronary artery for later induction
of CAO (3, 16). The abdominal cavity was opened, the anterior
mesenteric artery was freed from surrounding tissue, and a
loose suture was placed around the artery to facilitate later
MAO with an atraumatic clamp (see Ref. 3 for details). Core
temperature was monitored continuously using an electronic
thermometer (Electromedics) and was maintained between
36.5 and 37.5°C by either heating pads or ice-filled packages.
Experimental protocol BK blockade. After surgical prepara-
tion, rats were allowed 30 min for stabilization before base-
line hemodynamics were recorded. Rats were subdivided to
undergo one of six protocols (Fig. 1). All protocols included a
60-min CAO, followed by 180 min of reperfusion. This was
preceded by either no preconditioning (protocols 1 and 2),
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classic preconditioning by a 15-min CAO followed by a 10-min
reperfusion (protocols 3 and 4), or by remote preconditioning
by a 15-min MAO followed by a 10-min reperfusion (protocols
5 and 6). The experiments were performed in the absence
(protocols 1, 3, and 5) or presence (protocols 2, 4, and 6) of B2
receptor blockade by HOE-140 (300 µg/kg) administered
intravenously 10 min before preconditioning. The 15-min
CAO that is used as preconditioning stimulus, by itself
induces only negligible necrosis of 3 6 1% (3). HR and MAP
were recorded continuously and analyzed at the time points
depicted in Fig. 1. Rats that fibrillated during ischemia or
reperfusion were allowed to complete the protocol when
conversion to normal sinus rhythm occurred spontaneously or
when manual resuscitation was successful within 2 min after
onset of fibrillation. Occlusion and reperfusion were visually
verified by appearance and disappearance of myocardial or
small intestinal cyanosis.
Experimental protocol BK stimulation. Surgical prepara-
tion was slightly adjusted to include intramesenteric infusion
of BK, in that no suture was placed around the mesenteric
artery but one of the side branches was cannulated with the
catheter tip positioned at the edge of the mainstream of the
mesenteric artery (7). After surgical preparation, rats were
allowed 30 min for stabilization before baseline hemodynam-
ics were recorded. Rats were subdivided for three protocols
(Fig. 2). All protocols again included 60 min of CAO, followed
by 180 min of reperfusion. This was preceded by 5 min of
intramesenteric infusion of saline or BK, followed by 5 min of
rest. BK was infused at 1 µg/min, which is reported to
stimulate sensory neurons without direct systemic hemody-
namic effects (7). Whether the effects of intramesenteric BK
infusion on myocardial infarct size could indeed be attributed
to nerve stimulation rather than to circulating BK was
further verified by blockade of the nervous pathway by
hexamethonium (20 mg/kg iv) 15 min before the intramesen-
teric BK infusion. HR and MAP were recorded continuously
and analyzed at the time points shown in Fig. 2.
Measurement of area at risk and infarcted area. At the end
of each experiment the heart was quickly removed and placed
in ice-cold saline before it was mounted on a modified
Langendorff apparatus and perfused with cold saline via the
aorta to wash out the blood. After the coronary artery ligature
was retied, the heart was perfused with trypan blue (0.4%,
Sigma Chemical) to stain the perfused myocardium blue,
whereas the area at risk (AR) remains unstained. The heart
was placed at 280°C for 10 min before it was cut in slices (1
mm thickness) from apex to base. From each slice, the right
ventricle was removed and the left ventricle (LV) including
the septum was divided into the AR and the remaining LV.
The AR was then incubated for 10 min in 37°C nitro blue
tetrazolium (Sigma Chemical; 1 mg/ml So¨rensen buffer, pH
7.4), which stains vital tissue purple but leaves irreversibly
damaged tissue unstained [the infarct area (IA)]. After the IA
was separated from the noninfarcted area, the right ventricle
as well as the different areas of the LV were dried and
weighed separately.
Evaluation of dose of HOE-140. To effectively inhibit the
effects of BK during the experimental protocol, the dose and
duration of HOE-140 were evaluated in separate rats. For
that, rats were anesthetized with pentobarbital sodium and
catheters were implanted in the femoral artery as well as the
femoral vein (for detailed description see Surgical and experi-
mental preparation). The former was connected to a pressure
transducer for registration of MAP, whereas the latter was
used for intravenous administration. After at least 30 min of
stabilization, rats were injected with BK (4 µg/kg iv) and
blood pressure decrease was measured. This procedure was
repeated 5 min later to examine possible tachyphylaxis.
HOE-140 (300 µg/kg) was then injected and the blood pres-
sure response to BK was followed for 4 h.
Data analysis and presentation. Data are presented as
means 6 SE unless indicated otherwise. Correlation between
AR and IA was evaluated by linear regression analysis.
Differences in the IA-to-AR ratios (IA/RA) between groups
were analyzed using one-way ANOVA followed by Bonferro-
ni’s t-tests for multiple group comparisons. HR and MAP for
the different groups were analyzed by two-way ANOVA for
repeated measurements. Differences were regarded statisti-
cally significant at P , 0.05.
RESULTS
Mortality. A total of 71 rats entered the study.
Fifty-two of these rats completed their protocol and
have been included in the final analysis. The main
cause of exclusion was premature death (17 rats) due to
Fig. 1. Schematic presentation of 6 protocols in
which effect of Hoechst 140 (HOE-140; m) on risk
area and infarct size was studied. l, Measurements
of heart rate and blood pressure. CAO, coronary
artery occlusion; MAO, mesenteric artery occlusion;
Rep, reperfusion.
Fig. 2. Schematic presentation of 3 protocols in
which effect of intramesenteric bradykinin (BK) in
absence or presence of hexamethonium (Hex, m) on
risk area and infarct size was studied. l, Measure-
ments of heart rate and blood pressure.
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sustained ventricle fibrillation and/or hypotension dur-
ing the 180-min reperfusion period.
Evaluation of dose of HOE-140. BK, administered
intravenously at a dose of 4 µg/kg, decreased MAP by
23 6 3 mmHg. The second administration 5 min later
induced similar MAP reduction, indicating no tachyphy-
laxis. HOE-140 by itself had no effect on MAP or HR but
completely blocked the response to BK for at least 90
min. At 120 min the response was still inhibited by
70%, whereas at 210 min the response to BK was fully
restored.
BK blockade. Hemodynamics were registered continu-
ously by means of MAP and HR. Significant differences
were not observed for MAP or for HR among the
protocols at any time point (Fig. 3). Moreover, adminis-
tration of HOE-140 or ischemia and reperfusion did not
cause significant changes in HR and MAP.
Without preconditioning, a significant correlation
between AR and IA is observed (regression line, IA 5
0.54; RA, 16.25; r 5 0.894). Pretreatment with HOE-
140 does not change that (Fig. 4), resulting in similar
IA/AR as presented in Table 1.
Remote preconditioning by MAO resulted in pro-
nounced cardiac protection, as indicated by the position
of the points with respect to the regression line of
control hearts in Fig. 4. This cardiac protection was
completely abolished by HOE-140 (Fig 4). Accordingly,
IA/AR was significantly lower after remote precondition-
ing and normalized by HOE-140 (Table 1).
Classic preconditioning by CAO resulted in similar
protection as remote preconditioning and was also
completely abolished by HOE-140. This was substanti-
ated by the IA/AR (see Table 1).
BK stimulation. Saline infusion in the mesenteric
vascular bed did not affect MAP, HR, or infarct ratio,
and was similar to the control group of protocol 1.
Therefore, data of intramesenteric BK infusion were
compared with the control data of protocol 1. Although
Fig. 3. Heart rate and blood pressure at different time
points in protocols described in Fig. 1: A, after 30 min of
stabilization; B, 10 min after injection of saline or
HOE-140; C, at end of 15-min control, coronary or
mesenteric artery occlusion; D, after 10 min of reperfu-
sion; E, at end of 60-min CAO; F, at end of 3-h coronary
reperfusion.
Fig. 4. Infarct area (IA) plotted against
area at risk (AR) as percentage of left
ventricular weight for different proto-
cols. Regression line for controls is de-
picted in left panel of A. Because HOE-
140 did not change regression line for
controls in remaining panels, combined
regression line for controls is displayed.
A: without HOE-140 treatment. B: with
HOE-140 treatment.
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transiently BK infusion caused a slight increase in HR
and MAP, steady-state hemodynamics after 5 min of
infusion were not significantly altered. Pretreatment
with hexamethonium caused a significant reduction in
HR and MAP, which was not further altered by BK
infusion (Fig. 5).
Whereas intramesenteric infusion of saline had no
effect on infarction of the heart, 5 min of intramesen-
teric BK infusion, followed by 5 min of rest before the
60-min CAO resulted in significant cardiac protection
(Table 1). Protection was abolished by pretreatment
with the ganglion blocker hexamethonium.
DISCUSSION
In the present study we investigated the role of BK in
the remote cardiac preconditioning by mesenteric ar-
tery occlusion-reperfusion. The working hypothesis was
that BK that is locally released during ischemia-
reperfusion in the mesenteric bed stimulates sensory
nerves projecting on efferent nerves to the heart. The
hypothesis is supported by our findings that 1) HOE-
140, an antagonist for the B2 receptor involved in
sensory nerve stimulation, completely abolished the
cardiac protection by mesenteric ischemia-reperfusion;
2) intramesenteric BK, at a dose that stimulates sen-
sory nerves without systemic effects, could mimic car-
diac protection by mesenteric ischemia-reperfusion;
and 3) the protective effects of intramesenteric BK can
be completely blocked by the ganglion blocker hexame-
thonium.
BK blockade. The B2 receptor is reported to be the
receptor involved in vasodilation as well as sensory
nerve stimulation (9) and can be antagonized by HOE-
140. In pentobarbital sodium-anesthetized rats, intra-
venous BK induces a maximal decrease in MAP of ,25
mmHg at a dose of 10 µg/kg (pilot studies). In the
present study 4 µg/kg were used as a submaximal dose
to examine the time course of BK response inhibition
after 300 µg/kg HOE-140 (19). HOE-140 was capable of
blocking the response to BK completely for at least 90
min, which meant that the preconditioning protocols
were performed under B2 blockade up until at least the
60-min CAO. The effect of HOE-140 is waning during
the 180-min reperfusion period.
Pretreatment with HOE-140 had no effect on infarct
size of non-preconditioned rats. This is in general
accordance with earlier findings in other studies (2, 4).
However, HOE-140 completely abolished the cardiac
protection of the remote (by MAO) as well as the classic
(by CAO) preconditioning.Attenuation of classic precon-
ditioning by HOE-140 has been reported before but
appeared to occur in vivo (4, 21) rather than in vitro (2,
18). Moreover, cardiac protection could be obtained by
intracoronary BK infusion in vitro (2, 18) as well as in
vivo (21). In our previous study (3), in contrast to
remote preconditioning, classic preconditioning could
not be inhibited by hexamethonium nor had hexametho-
nium itself cardioprotective effects. Thus although sen-
sory nerves may be present on the ventricle, which
could induce efferent nerve stimulation to the heart,
results suggest a local effect of BK on the heart rather
than the aforementioned neurogenic pathway. This
would be in accordance with the study of Goto et al. (4),
who suggested that blood-borne kininogens rather than
autonomic nerves would be involved in classic precondi-
tioning.
Table 1. IA-to-AR ratio for different protocols
n AR, %LV IA/AR
Control 8 6065 6265
Control1HOE-140 6 5069 5866
CAO 6 5267 3763*
CAO1HOE-140 6 5565 7166†
MAO 6 5267 3565*
MAO1HOE-140 6 4968 6567†
Saline 3 53614 5264
Bradykinin 7 5565 2663*
Bradykinin1Hex 6 5065 6764†
Values are means 6 SE; n 5 no. of rats studied. AR, area at risk; IA,
infarct area; CAO, classic preconditioning by coronary artery occlu-
sion; MAO, remote preconditioning by mesenteric artery occlusion;
HOE-140, Hoechst 140 pretreatment; Hex, hexamethonium pretreat-
ment. *Significant effect compared with control. †Significant effect of
HOE-140 or Hex pretreatment on respective cardiac protection.
Fig. 5. Heart rate and blood pressure at different time
points in protocols described in Fig. 2: A, after 30 min of
stabilization; B, 10 min after injection of saline or
hexamethonium; C, at end of 5-min intramesenteric
saline or BK infusion; D, just before 60-min CAO; E, at
end of 60-min CAO; F, at end of 3-h coronary reperfu-
sion.
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In contrast, remote preconditioning could well be
associated with stimulation of a neurogenic pathway,
because cardiac protection can be attenuated through
ganglion blockade by hexamethonium (3). However,
similar to classic preconditioning, pretreatment with
HOE-140 completely abolished the cardiac protection
of 15 min of MAO. This result indicates that endog-
enous BK has an important role in the neurogenic
pathway of remote preconditioning.
Locally infused BK in the mesenteric vascular bed
could mimic remote cardiac preconditioning by reduc-
tion of myocardial infarct size. The calculated local
concentration of BK (1 µg/min BK into 615 ml/min
mesenteric flow results in 67 µg/l 5 55 nM) of 55 nM at
intramesenteric infusion closely resembles the cardiac
BK concentrations with classic preconditioning in pigs,
from 30 nM at baseline to 60 nM during ischemia-
reperfusion (17).
The protection could be prevented by ganglion block-
ade. Because we showed that intravenous injection of
BK decreased blood pressure (as we used to determine
duration of action of HOE-140) the slight increases of
HR and MAP after intramesenteric BK infusion sug-
gest a locally induced rather than a systemic effect. The
cardiac protection observed after intramesenteric BK
therefore could be attributed to an action of BK in the
mesenteric bed rather than the well-known effects of
circulating BK on the heart itself (2, 4, 18, 21).
The route of administration and the dose of local BK
in the present study have been reported to stimulate
afferent mesenteric nerves (7), but we cannot exclude
effects of BK leaking into the systemic circulation.
However, the observation that the cardioprotective
effect of intramesenteric BK infusion could be pre-
vented by ganglion blockade with hexamethonium sug-
gests a neuronal rather than a circulating mechanism.
This is supported by the observation that intramesen-
teric injection of capsaicin, at a dose that stimulates but
does not desensitize sensory nerves (22), caused similar
cardioprotection as BK (data not shown).
However, we cannot exclude one hypothetical mecha-
nism for the remote preconditioning. Because BK also
has been reported to have a role in sensory function in
other organs and even up to the level of the spinal cord
(11), which may include hexamethonium-sensitive path-
ways as well, intramesenteric infused BK could have
leaked out to other organs, including the heart or the
spinal cord, and have exerted its neuronal stimulation
there.
In addition to a direct role of BK in sensory function
(11), intramesenteric BK infusion caused a substantial
reduction of mesenteric blood flow (7). Regarding the
slightly increased MAP, this may result in 640%
increase in mesenteric vascular resistance at the dose
of BK used (7). This by itself could cause mesenteric
ischemia, which, as we have shown, may result in
cardiac protection (present study and Ref. 3). Thus
whether intramesenteric endogenous or exogenous BK
directly stimulates afferent nerves or acts in associa-
tion with mesenteric ischemia-reperfusion is not known.
The mechanism at the other end of the neurogenic
pathway, that is on the heart, is not yet clear. Iwamoto
and co-workers (6) indicate that the heart can be
preconditioned by stimulation of the left stellate car-
diac nerve, if simultaneously the increase in coronary
blood flow was restricted. Moreover, cardiac precondi-
tioning can be achieved by increasing endogenous
catecholamine release (1). These studies indicate that
under certain conditions the sympathetic nervous sys-
tem may have a role in cardiac preconditioning. More-
over, two recent studies (14, 20) indicate that cardiac
adenosine receptors may be involved in remote precon-
ditioning by renal artery occlusion-reperfusion. Adeno-
sine activates a pertussis toxin-sensitive inhibitory G
protein, which can facilitate the activation of ATP-
sensitive K1 channels. Stimulation of a-adrenoceptors
by endogenous catecholamines can exert precondition-
ing effects through the activation of protein kinase C
via such a G protein (5). However, further investigation
is needed for its role in remote preconditioning.
In conclusion, data from the present study showed
evidence for an important role for BK in remote precon-
ditioning. Results support the hypothesis that remote
preconditioning could act through sensory nerve stimu-
lation in the ischemic organ. The consecutive mecha-
nism within the heart is not yet clear but may involve
the endogenous release of catecholamines.
HOE-140 was a generous gift of Hoechst, Germany.
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